Cargando…

Anti-ulcerogenic and anti-ulcerative colitis (UC) activities of seven amines derivatives

The Novel target compounds (CP-1-7) were synthesized and tested at doses up to 1000 mg/kg for their entitled activities. They exerted promising results without any behavioral changes and mortality in mice. Therefore, according to the results obtained in our study, it could be categorized as highly s...

Descripción completa

Detalles Bibliográficos
Autores principales: Awaad, Amani S., Alafeefy, Ahmed M., Alasmary, Fatmah A.S., El-Meligy, Reham M., Alqasoumi, Saleh I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111114/
https://www.ncbi.nlm.nih.gov/pubmed/30166899
http://dx.doi.org/10.1016/j.jsps.2017.07.003
_version_ 1783350593737195520
author Awaad, Amani S.
Alafeefy, Ahmed M.
Alasmary, Fatmah A.S.
El-Meligy, Reham M.
Alqasoumi, Saleh I.
author_facet Awaad, Amani S.
Alafeefy, Ahmed M.
Alasmary, Fatmah A.S.
El-Meligy, Reham M.
Alqasoumi, Saleh I.
author_sort Awaad, Amani S.
collection PubMed
description The Novel target compounds (CP-1-7) were synthesized and tested at doses up to 1000 mg/kg for their entitled activities. They exerted promising results without any behavioral changes and mortality in mice. Therefore, according to the results obtained in our study, it could be categorized as highly safe agents for treating UC since substances possessing LD(50) higher than 50 mg/kg are considered nontoxic. They also possessed a potent anti-ulcerogenic activity with different potentials. The most effective compound was CP-4, it produced 97.7% ulcer protection of control followed by CP-3, which produced 90.3% protection, while the standard drug ranitidine (100 mg/kg) produced 49.2% protection. Compound CP-1 showed lowest activity among the current series, it produced 55.5% protection. The target compounds were significantly more effective than the standard in reducing ulcer index. The anti-ulcerative colitis activity was tested using acetic acid induced colitis model. The curative effect of the tested compounds at a dose of 50 mg/kg oral administration on rats showed a potent anti-ulcerative colitis activity with different potentials. They induced a significant decrease in ulcer score, ulcer area, ulcer index and weight/length of the colon specimens. The percent protection of control colitis ranged from 66.8% for CP-7 to 22.3% for CP-5; however the percent protection for dexamesathone (0.1 mg/kg) was 59.3%. The effect of the tested compounds CP-7 and CP-3 at dose 50 mg/kg were significantly more effective than dexamesathone (0.1 mg/kg) in reducing all parameters. Liver functions were not affected as there is no effect on the activity of both AST and ALT in animals that received the compounds, so the compounds didn’t reveal hepatotoxic manifestation. Although, the results on kidney functions showed that, CP-1 slightly elevated blood urea concentration and CP-3 & CP-4 slightly elevated serum creatinine; no apparent nephrotoxic manifestations were recorded.
format Online
Article
Text
id pubmed-6111114
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-61111142018-08-30 Anti-ulcerogenic and anti-ulcerative colitis (UC) activities of seven amines derivatives Awaad, Amani S. Alafeefy, Ahmed M. Alasmary, Fatmah A.S. El-Meligy, Reham M. Alqasoumi, Saleh I. Saudi Pharm J Original Article The Novel target compounds (CP-1-7) were synthesized and tested at doses up to 1000 mg/kg for their entitled activities. They exerted promising results without any behavioral changes and mortality in mice. Therefore, according to the results obtained in our study, it could be categorized as highly safe agents for treating UC since substances possessing LD(50) higher than 50 mg/kg are considered nontoxic. They also possessed a potent anti-ulcerogenic activity with different potentials. The most effective compound was CP-4, it produced 97.7% ulcer protection of control followed by CP-3, which produced 90.3% protection, while the standard drug ranitidine (100 mg/kg) produced 49.2% protection. Compound CP-1 showed lowest activity among the current series, it produced 55.5% protection. The target compounds were significantly more effective than the standard in reducing ulcer index. The anti-ulcerative colitis activity was tested using acetic acid induced colitis model. The curative effect of the tested compounds at a dose of 50 mg/kg oral administration on rats showed a potent anti-ulcerative colitis activity with different potentials. They induced a significant decrease in ulcer score, ulcer area, ulcer index and weight/length of the colon specimens. The percent protection of control colitis ranged from 66.8% for CP-7 to 22.3% for CP-5; however the percent protection for dexamesathone (0.1 mg/kg) was 59.3%. The effect of the tested compounds CP-7 and CP-3 at dose 50 mg/kg were significantly more effective than dexamesathone (0.1 mg/kg) in reducing all parameters. Liver functions were not affected as there is no effect on the activity of both AST and ALT in animals that received the compounds, so the compounds didn’t reveal hepatotoxic manifestation. Although, the results on kidney functions showed that, CP-1 slightly elevated blood urea concentration and CP-3 & CP-4 slightly elevated serum creatinine; no apparent nephrotoxic manifestations were recorded. Elsevier 2017-12 2017-07-11 /pmc/articles/PMC6111114/ /pubmed/30166899 http://dx.doi.org/10.1016/j.jsps.2017.07.003 Text en © 2017 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Awaad, Amani S.
Alafeefy, Ahmed M.
Alasmary, Fatmah A.S.
El-Meligy, Reham M.
Alqasoumi, Saleh I.
Anti-ulcerogenic and anti-ulcerative colitis (UC) activities of seven amines derivatives
title Anti-ulcerogenic and anti-ulcerative colitis (UC) activities of seven amines derivatives
title_full Anti-ulcerogenic and anti-ulcerative colitis (UC) activities of seven amines derivatives
title_fullStr Anti-ulcerogenic and anti-ulcerative colitis (UC) activities of seven amines derivatives
title_full_unstemmed Anti-ulcerogenic and anti-ulcerative colitis (UC) activities of seven amines derivatives
title_short Anti-ulcerogenic and anti-ulcerative colitis (UC) activities of seven amines derivatives
title_sort anti-ulcerogenic and anti-ulcerative colitis (uc) activities of seven amines derivatives
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111114/
https://www.ncbi.nlm.nih.gov/pubmed/30166899
http://dx.doi.org/10.1016/j.jsps.2017.07.003
work_keys_str_mv AT awaadamanis antiulcerogenicandantiulcerativecolitisucactivitiesofsevenaminesderivatives
AT alafeefyahmedm antiulcerogenicandantiulcerativecolitisucactivitiesofsevenaminesderivatives
AT alasmaryfatmahas antiulcerogenicandantiulcerativecolitisucactivitiesofsevenaminesderivatives
AT elmeligyrehamm antiulcerogenicandantiulcerativecolitisucactivitiesofsevenaminesderivatives
AT alqasoumisalehi antiulcerogenicandantiulcerativecolitisucactivitiesofsevenaminesderivatives